Paul Wright, MD
Neurology · Poughkeepsie, NYNPI 1275510828
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Biogen at 51.5% of the total.
Across 22 payments — averaging $335.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$4K
- Bayer$4K
- Medtronic$39
- AbbVie$24
- Strongbridge US Inc.$13
Across 2 payments — averaging $3381.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$7K
What the payments were for
- Consulting fees$3,17443%
- Speaking & faculty fees$2,26031%
- Travel & lodging$1,09515%
- Food & beverage$79911%
- Education$431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 4 | $3,794 |
| Bayer | 14 | $3,501 |
| Medtronic(2 entities) | 2 | $39 |
| AbbVie | 1 | $24 |
| Strongbridge US Inc. | 1 | $13 |
How this compares
$7,370 in reported general payments places this provider in the 75th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 12 | $5,384 |
| Memantine Hcl | 124 | $5,259 |
| Levetiracetam | 64 | $2,842 |
| Pyridostigmine Bromide | 20 | $2,442 |
| Donepezil Hcl | 203 | $2,122 |
| Gabapentin | 83 | $1,693 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 59 | $1,176 |
| Escitalopram Oxalate | 78 | $818 |
| Baclofen | 15 | $483 |
| Duloxetine Hcl | 31 | $478 |
| Quetiapine Fumarate | 34 | $459 |
| Atorvastatin Calcium | 15 | $329 |
| Lamotrigine | 15 | $319 |
| Topiramate | 17 | $238 |
| Mirtazapine | 15 | $181 |
Paid to pharmacies, not to this prescriber.
Other neurology in Poughkeepsie
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
- Richard LiptonBronx$753K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.